<DOC>
	<DOCNO>NCT02006056</DOCNO>
	<brief_summary>The primary objective study examine efficacy Ondissolve prevention/rescue Acute Delayed Phase radiation induce nausea vomiting ( RINV ) patient undergo single multiple fraction , emetogenic palliative radiation therapy painful bone metastasis . The study population 30 patient see RRRP Sunnybrook Odette Cancer Centre receive palliative radiation therapy consider emetogenic bone metastasis . Patients take study medication ( Ondissolve 8 mg ) twice day radiation therapy , least one hour prior treatment repeat approximately 6-8 hour later day . Patients undergo multiple fraction radiation therapy take Ondissolve weekend holiday treatment . Secondary objective include evaluate key secondary endpoint related RINV , investigate ease length administration protocol medicine . We hypothesize Ondissolve effective prophylaxis RINV , ease use administration provide appropriate delivery method unable tolerate oral form ondansetron .</brief_summary>
	<brief_title>Ondissolve Prophylaxis/Rescue Radiation Induced Nausea Vomiting</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<criteria>Informed consent Patient receive palliative radiation therapy consider emetogenic bone metastasis . Group 1 : At least mild nausea and/or least mild vomit record Baseline Nausea Vomiting Data Collection Sheet Group 2 : Nausea vomit record 'none ' Baseline Nausea Vomiting Data Collection Sheet Patient schedule receive cranial radiation therapy within 10 day follow completion protocol RT . Patient receive cranial RT within 7 day prior commencement protocol RT . Patient schedule receive chemotherapy within 10 day follow completion protocol RT . Patient receive moderately highly emetogenic chemotherapy within 7 day prior commencement protocol RT . Patient schedule change regimen/dose start use corticosteroid ( inhaled topical permit ) , medication consider antiemetic activity within 48 hour protocol RT . Patient schedule change regimen/dose start use corticosteroid ( inhaled topical permit ) , medication consider antiemetic activity within 10 day follow completion protocol RT . Patient allergic protocol medication . Patient Karnofsky Performance Status score &lt; 40 . Patient woman pregnant childbearing potential use contraceptive measure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>